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Background: No consensus exists on the exact treatment of pneumothorax (PTX). Some guide-
lines are proposing manual aspiration (MA) to be preferred over tube thoracostomy (TT) in
uncomplicated primary spontaneous pneumothorax (PSP). However, only a few studies re-
ported a direct comparison of both methods. Our aim was to re-evaluate this with a randomised
trial in a single centre in the Netherlands.
Methods: Patients with a first episode of symptomatic PTX admitted to the ER or asymptomatic
PTX with a size of 20% were recruited during 2007e2009 and followed-up for one year. Ran-
domisation between MA and TTwas balanced by a computer minimisation program for cause of
PTX, smoking and gender. When first MA attempt failed, a second attempt was not undertaken
and patients underwent TT. (registered at ClinicalTrials.gov (NCT00556335).
Results: 56 patients were included. Baseline characteristics were similar. Immediate success
rates were 68.0% for MA versus 80.6% for TT (p Z 0.28). Two week success rates were 100%
in both groups. There was a significant difference in hospital stay in favour of MA: 2.4  2.6
versus 4.4  3.3 days (p Z 0.02). One year recurrence rates in MA were lower than in TT,
although not statistically significant (4.0% and 12.9% p Z 0.37). Predictors of immediate
success were traumatic PTX and female sex. One patient died during follow-up due to heart
failure.
Conclusion: MA is simple, safe, cheap, minimal invasive in uncomplicated PSP/traumatic PTX
with similar success and recurrence rates and a shorter hospital stay in comparison to TT and
therefore the treatment of choice.
ª 2012 Elsevier Ltd. All rights reserved.8 42 42 456; fax: þ31 38 42 43 158.
nl (M. Parlak), s.m.uil@isala.nl (S.M. Uil), j.w.k.van.den.berg@isala.nl (J.W.K. van den Berg).
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Primary spontaneous and traumatic pneumothorax (TPTX)
are common pathologies in daily pulmonary practice that
account for significant health-care expenditures.1,2
A primary spontaneous pneumothorax (PSP) is defined as
a spontaneously occurring PTX in a person without an
underlying lung disease.3 TPTX is a PTX due to a trauma of
variable origin. Incidence is estimated at 18e28 per
100,000 males and 1.2e6 per 100,000 females.4 Hospital
admission rates for combined primary and secondary PTX
are reported between 16.7 per 100,000 men per year and
5.8 per 100,000 women per year.5 A PTX is called secondary
when caused by underlying parenchymal lung diseases
predisposing to PTX like emphysema, pulmonary fibrosis of
any cause, cystic fibrosis, aggressive or cavitating pneu-
monia and cystic interstitial lung diseases such as Langer-
hans’ cell histiocytosis and lymphangiomyomatosis.6
A secondary pneumothorax (SPTX) is the result of distal
airway inflammation and obstruction due to internal
(bronchial abnormalities)7 and external factors (smoking).8
Distal airway obstruction may lead to the development of
emphysema-like changes increasing the chance on ruptures
leading to visceral pleural air leaks, the development of
direct visceral pores9 or to mediastinal pleural leaks.10 The
treatment of choice for PSP is influenced by clinical
presentation, size, recurrence risk, daily activities, patient
preference and economical considerations. Treatment
options consist of the following: therapeutic abstinence
(bed rest and oxygen), TT, MA and immediate thoracoscopic
or even open surgical intervention (thoracotomy). The size
of a PSP estimated by means of the Light index correlates
strongly with the amount of air present in the pleural
space.3 In asymptomatic patients with a PTX size less than
20% of the hemithorax no treatment is recommended.
Active treatment is required in symptomatic patients and/
or a PTX size 20%; efforts to remove the air and expand
the lung are indicated.11 Treatment options and recom-
mendations vary related to the differences in treatment
goals1: simple air removal versus prevention of recurrences
in combination with the availability of only a few
prospective, comparative studies.12 Whether to treat
patients presenting with a first episode of PSP with a form
of pleurodesis treatment or to wait for a first recurrence
should be decided after analysis of recurrence risk and
direct and indirect costs of the procedure.1,13 Schramel and
colleagues suggest that Video-Assisted Thoracic Surgery
(VATS) is more effective in first or recurrent PTX than TT
resulting in less morbidity and costs, hereby recommending
that all symptomatic patients should be subjected to
thoracoscopy.14 However, this is a very aggressive approach
since half of the patients who develop an initial PSP will
never have another3 and most of these patients underwent
surgery unnecessarily.14 Nevertheless, no consensus has
been defined concerning the exact treatment of PTX
patients. A consensus statement from the American College
of Chest Physicians recommended that the pleural air be
removed via placement of a small bore catheter (14 F) or
a 16 Fe22 F chest tube that may be attached to a Heimlich
valve or to a water seal device.1 In contrast the British
Thoracic Society guidelines for the management of PSPrecommend the removal of pleural air by aspiration. When
post-aspiration chest radiograph reveals that the PTX is
small or resolved, the system could be removed and the
patient not be hospitalised.15 The British Thoracic Society
Research Committee study detected similar success rates
for MA and TT in first PSP episodes with MA being less
painful. Lower admission rates and a reduction in pleur-
ectomy need without an increase in one year recurrency
were other benefits of MA.16
Nowadays regular therapy of PSP consists mostly of TT
which is associated with higher levels of pain and anxiety
requiring opioid premedication and local anaesthesia4 and
a longer hospital stay with higher costs without a significant
difference in immediate and recurrence rates in compar-
ison to MA.12 In conclusion literature suggests similar
immediate and long-term efficacy of MA and TT. Because of
its minimal morbidity, simplicity, non-invasiveness (less
pain), outpatient-based implementation, safety, equal
efficacy in comparison to TT12,17 and low cost by MA fol-
lowed by immediate discharge and follow-up, several trials
are advocating MA as the treatment of choice in uncom-
plicated PSP.12,13,15,17,18 Our effort was to confirm the
former findings with a mono-centred study set-up for the
first time in the Netherlands. The study aimed to evaluate
the efficacy of MA in comparison to TT in PTX therapy;
whether MA will shorten hospital admission and whether
the lung will expand assessed by means of clinical and
radiological findings.
Methods
Study design
Our study is a mono-centred prospective parallel group
randomised (1:1 ratio) controlled trial during 2007e2009
with a one year follow up performed in the Isala klinieken in
Zwolle, the Netherlands. Approval of the local ethics
committee was achieved. This trial is registered at
ClinicalTrials.gov (NCT00556335).
Study population
Patients with an age between 18 and 85 years with a first
episode of a symptomatic (spontaneous or traumatic) PTX
admitted to the ER of the hospital or patients with an
asymptomatic pneumothorax (APTX) with a size of 20% as
estimated by Light’s formula ((1 minus length divided by
height) multiplied by 100) were recruited. Exclusion
criteria were pregnancy, severe comorbidity, prior ran-
domisation, recurrent or tension PTX, limited decision
making, patients with a chronic lung disease, HIV or Marfan
syndrome.
Randomisation
After written informed consent was given, patients were
randomised by a computer minimisation program between
MA or TT initiated by the doctor at the ER. The minimisation
program balanced patients for the following factors: cause
of PTX (spontaneous or traumatic), smoking status (past,
Table 1 Patient characteristics.
Manual
aspiration
Chest tube
drainage
n 25 31
Sex, m/f (%m) 17/8 (68) 23/8 (74)
Age, yrs 47  19 40  20
Total pneumothorax (%) 15/25 (60) 22/31 (71)
Affected side (right/left;
%right)
8/17 (32) 15/16 (48)
Light indexa 60.5  25.4 63.8  22.8
Spontaneous/traumatic
cause (%spontaneous)
14/11 (56) 20/11 (65)
Body mass index (kg/m2) 23.9  3.1 22.0  3.1
Current smoker (%) 13/25 (52) 16/31 (52)
a One missing in MA group and three missing in TT group.
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went MA or TT according to protocol.
Interventions
Patients with PSP or traumatic PTX admitted to the ER
underwent MA or TT. MA was performed as follows: After
skin desinfection and field preparation, an angio intrave-
nous (I.V.) catheter with a diameter of 1.3 mm was intro-
duced in the second or third intercostal space midclavicular
of the affected site after local anaesthesia (lidocaı¨ne 1%).
In case of extreme obesity a pneumocatheter was used.
After fixation to the skin, the I.V. catheter was connected
with a three-way valve to a 50 ml syringe and air was
manually aspirated until a resistance was felt and no air
was acquired any longer. In case of success with an
expanded lung at the chest X-ray, the drainage system was
disconnected and patient was observed during 24 h. If MA
had failed, no second attempt was made and TT was
chosen. After the observation period a new chest X-ray was
made with a final evaluation. When the lung was still
expanded at the chest X-ray, discharge followed. When no
lung expansion was reached or in case of absorption of
>2000 ml air (prolonged air leak), TT drainage was
performed.
Chest tube drainage was initially perfomed like MA. The
difference consisted of connection of a drain to a drainage
system (tube thoracostomy with two reservoirs; Abbott
laboratories) with a negative pressure of 10 mmHg H2O.
When airway leakage has ceased, expansion of the lung was
radiologically evaluated. The drain was clipped for 4 h
when the lung was expanded. When expansion of the lung
still existed after 4 h, the drain was removed and patient
was discharged. After discharge patients were seen at day
seven and after one year at the outpatient clinic with
a chest X-ray to evaluate a possible recurrence of the PTX.
Otherwise patients with complaints were seen earlier.
Study endpoints
The main study endpoint was the duration of hospital stay.
The secondary study endpoint was immediate success rate
defined as complete success after first attempt (without
need for TT) with discharge after 24 h for NA (needle
aspiration). MA success was defined as a complete expan-
sion, success rate at two weeks (continuous expansion) and
one year (no recurrence of PTX in the interval period).
Immediate TT success was defined as expansion of the lung,
counteraction of the air leak and removal of the drain with
discharge within 72 h. Finally, predictors for immediate
success were assessed.
Sample size calculation
Sample size calculation was based on results of the Noppen
study.12
The following data were used: mean hospital stay of
population 1: 3.4, mean hospital stay of population 2: 4.5,
common standard deviation: 2.0, significance level: 0.05.
The study had 80% power to demonstrate a difference of
one day in hospital stay between MA and TT. Allowing for10% withdrawal, we aimed to recruit 114 patients (n Z 57
for both groups).
Statistical analysis
Baseline characteristics were described using descriptive
statistics. The main study endpoint (hospital stay) was
analysed with the Student’s t-test (2-tailed) for indepen-
dent groups. Success rates were assessed with the chi-
squared test or Fisher’s exact test when appropriate.
Multivariate logistic regression was used to assess predict-
ing factors associated with immediate success. Statistical
significance was accepted as a p < 0.05. Data analysis was
performed using SPSS version 18.Results
Recruitment fell short of expectation and finally, 56
patients were included (n Z 25 MA and n Z 31 TT) during
2007e2009. As a result the power of the study decreased
from 80% to 54%. Patient characteristics for each group are
listed in Table 1. There were no differences in gender, age,
percentage of total PTX, PTX size (Light index), body mass
index (weight in kilogrammes divided by height in m2) and
smoking status. In the MA group, the left side was more
frequently affected. There was one missing Light index in
the MA and three missing in the TT group. A study flow chart
is given in Fig. 1. There was a significant difference in
hospital stay in favour of MA: 2.4  2.6 versus 4.4  3.3
days (p Z 0.02). Immediate success rates were not signif-
icantly different in both groups: 17/25 (68.0%) of MA
patients versus 25/31 (80.6%) of TT (p Z 0.28). Of the 8
patients in whom MA was unsuccessful, TT was successful
within two weeks. Two week success rates were 25/25
(100%) for MA patients and 31/31 (100%) for TT. The 1 year
recurrence rates were not significantly different for both
groups: 1/25 (4.0%) for MA versus 4/31 (12.9%) for TT
(pZ 0.37). Predictors of immediate success were TPTX and
female sex independent of type of treatment (Table 2).
One patient died during follow up of our study due to heart
failure (cardiomyopathy).
Table 2 Predictors of immediate success (72 h).
Predictor Odds ratio 95%CI p-value
Cause (traumatic versus
spontaneous)
11.1 1.3; 95.4 0.028
Sex (female versus man) 5.6 0.6; 50.8 0.124
95%CI: 95% confidence interval.
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Our study is the first prospective, randomised mono-
centred study in the Netherlands comparing MA and TT as
a first treatment for patients presenting with a first episode
of PSP. This study was based on the study of Noppen et al.12
Fifty-six patients with a first episode of symptomatic PTX
admitted to the ER or asymptomatic PTX with a size of
20% were recruited during 2007e2009 and followed-up for
one year. There is no significant difference in success rates
between MA and TT either immediate or at two weeks.
Hospital stay however was significant shorter in MA.
Predictors of immediate success were traumatic PTX and
female sex, independent whether MA or TT was used.
PSP and TPTX are common pathologies in daily pulmo-
nary practice accounting for a significant health-care
expenditure.1,2 Generally accepted guidelines are lacking,
leading to a variation in daily practice.1 There is a general
consensus on a conservative approach in first episodes of
asymptomatic PSP and/or small pneumothoraces <20%
(Light index). In symptomatic patients or those with large
pneumothoraces treatment options could vary because of
treatment goals (simple removal or the prevention of
recurrence).1 This is caused by the lack of prospective,
studies comparing various treatment options in homoge-
nous patient populations. The way of treatment (simple
removal, pleurodesis or a VATS) of patients with a first
episode of PSP depends on the risk of recurrence (an
average of 30% after a first episode)12 and social factors56 PTX
25 MA
17 Success
≤72h
8 No success
≤72h
2 CTD 
+ VATS 6 CTD
8 Success
≤14 days
1 Recurrent
PTX ≤ 1yr
1 Success after
VATS
4
Figure 1 Flowchart of inclusion,(profession or preference of patient). The American College
of Chest Physicians recommended TT or pleural catheters
as the preferred intervention in the management of PSP.
Simple aspiration was advocated only for stable patients
with small pneumothoraces.1 VATS treatment is suggested
to be more cost effective than TT (even in first episodes)
but it is a fact that 73% of patients had unnecessary oper-
ations. Procedures to prevent recurrence should be
reserved for recurrent PTX. Although MA is simple, less
invasive and less costly,1,12,15 TT is the most popular and
recommended air evacuation technique. This could be
explained by the lack of affinity with MA as well as the
scarce and complex (heterogenous groups) literature. Some
authors argue against MA for the following reasons: the
absence of recurrence prevention, difficult to interpret
literature (inhomogeneous population) without a clear
consensus. The first point is irrelevant because patients
with recurrent PTX are not considered for MA and neither
MA nor TT has any recurrence prevention effect.19e21
Therefore surgery should be undertaken. The immediate
success of MA in literature ranges from 38% to 86%, (aver-
aging 72%). Late recurrences (at least 1-year follow-up)
vary between 0 and 30%. Complications are rare and not
life-treathening (haemothorax, retained catheter tips,
subcutaneous emphysema and vasovagal reactions). In the
British Thoracic Society Research Committee study17 MA
and TT were reported to be equally successful in first and
recurrent episodes of spontaneous (presumably primary)
PTX with MA being less painful, leading to less admission
rates and a reduced need for pleurectomy without an
increase in recurrence rate at one year. MA is recom-
mended as first line treatment for all PSP requiring inter-
vention. Despite the publication of these guidelines,
management of PSP continues to be characterised by
empiricism rather than being evidence-based.1
There are prospective, comparative studies on MA versus
TT in spontaneous PTX.17,22 In the study of Noppen imme-
diate MA had a success rate of 59.2% versus 63.6% (pZ 0.9)
in TT (complete success and discharge within 72 h).12 One-31 TT
25 Success
≤72h
6 No success
≤72h
4 CTD 1 CTD 
+ PD
6 Success
≤14 days
4 Recurrent
PTX ≤ 1yr
 Success after
VATS
1 CTD 
+ VATS
randomisation and follow up.
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group and 85% (p Z 0.4) in TT. In MA patients 52% was
hospitalised versus 100% in TT (p Z 0.0001). We achieved
almost the same results as Noppen. A significant shorter
hospitalisation was found for MA patients 2.4  2.6 in MA
versus 4.4  3.3 days in TT (p Z 0.02). No significant
differences in immediate success, 1 year success and one
year recurrence rates were seen. In contrast, we found
lower one year recurrence rates; 4.0% versus 26% for MA
and 13% versus 27.3% for TT. This could be explained by the
inclusion of more females (32% versus 26% in MA and 26%
versus 16% in TT) and patients with a traumatic PTX in our
study. Both traumatic PTX and female sex were found to be
predictors of immediate success. Probably this explained
the lower recurrence rate also.
In the Andrivet study,22 delayed needle aspiration (NA)
(72 h) was less effective (67% versus 93%) than immediate TT
(success was assessed up to 10 days after tube placement) in
the first part of their study. In the second part, immediate
NA was successful in 68.5% of patients. Hospital stay was
similar between both groups. Recurrence rates at 3 months
in the various treatment arms (manual versus thoracostomy)
did not differ significantly (21% versus 29%) (p > 0.45).
The study of Ayed showed comparable results: imme-
diate- and 1 week success rate of 62% and 89% for aspiration
versus 68% and 88% for the TT. Recurrence rates did not
differ significantly between both groups after 3, 12 and 24
months. Complication rates were 2% versus 7%.4 The study
population consisted mainly of males.
The trial of Harvey had an initial aspiration success rate
of 66%. The total higher MA success rate of 80% was
explained by second MA efforts in 14% of the patients. No
significant difference in one year recurrence rate was seen
between MA and TT. We confirmed the safety of MA in
literature, observing no side effects, complications or need
for urgent readmissions in the MA group.17
There were some limitations in our study. Our aim was to
enrol 114 patients. Unfortunately we did not reach this
sample size due to logistical reasons. Only 56 patients were
enrolled. This is the most important limitation of our study.
This decreased our study power. However, the current
sample based on hospital stay seemed sufficient enough to
demonstrate a significant difference. Otherwise our patient
number was similar with the study of Noppen: 56 versus 60
patients.12
The second limitation of our study (MA) is that large or
total pneumothoraces are not suitable for MA because this
exceeds the air drainage of 2 L. In the Noppen study the
cut-off point for MA was 4 L. Also the single attempt for
MA could be a limitation. A second aspiration was not likely
to be successful in the Noppen study.12 We did not inves-
tigate whether a second aspiration would lead to a failure.
That was the reason to exclude a second attempt by a first
failure in MA. However the Harvey study described second
MA with success in 14% of patients.17 Second MA failure
would be most probably due to a persistent air leak of
a large parenchymal tear leading to a high short term
recurrence, because MA does not promote pleural
symphysis.4 It was previously thought to be that the irri-
tating effect of the tube promotes pleural symphysis
thereby reducing the risk for a recurrent ipsilateral spon-
taneous PTX. Although this may be intuitively logical, it hasnot been validated by clinical studies because the recur-
rence rates between TT and MA were similar.22
Finally, we could not calculate the Light index in 4
patients; 3 in TT group and one in the MA group. This was
caused by a software problem in the imaging of chest X-
rays. Lastly we have not calculated costs, although shorter
hospitalisation may suggest a superior cost effectiveness
for MA as first line treatment in first episodes of PSP.
Although our study had some limitations, our results
meet literature figures: immediate MA success in literature
ranges from 38% to 86%. Late recurrences after MA vary
between 0 and 30% and show no significant difference with
TT.17,22e26 Hospital stay is significant different in MA
compared with TT.12 Our most important limitation is our
small sample size. However, former trials had included
similar sample sizes.12 In daily practice it is difficult and
time-consuming to include large populations. Especially,
when performed as a mono-centred study like we did.
There is a not significant difference in immediate success
rates between MA and TT. Maybe success rates of MA could
be increased by performing a second attempt.17 Until
future studies will recommend another approach, we will
perform MA as the treatment of choice in traumatic and
uncomplicated PSP with an exception of total
pneumothoraces.
Conclusion
MA is simple, safe, cheap, less invasive in patients with
traumatic and uncomplicated PSP with no significant differ-
ence in success and recurrence rates and a shorter hospital
stay in comparison to TT. In our opinion, MA is the treatment
of choice in pneumothoraces with an estimated air evacua-
tion<2 L. The treatment of large (total) pneumothoraces are
excluded. Further appropriately powered randomised clin-
ical trials employing a larger number of participants could be
undertaken to increase the insight in MA.
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